External reference pricing
Countries using external reference pricing (ERP) for medications cost-containment policies in 2018 or latest data.[1][2][3][4][5][6][7] Categories of medications include generics, patented, reimbursed-only or imported medicines.
ERP used as main criterion for at least one category of medications
ERP as at least a supportive information
Unknown criteria
Experimental or informal use of ERP
Not using ERP
Using internal reference pricing
External reference pricing (ERP), also known as international reference pricing, is the practice of regulating the price of a medication in one country, by comparing with the price in a "basket" of other reference countries. It contrasts with internal reference pricing, where the price of one drug is compared to the domestic price of therapeutically related drugs, and with cost-plus pricing, where the price involves negotiating an acceptable markup to the unit cost to develop and produce.[8]: 300
- ^ Cite error: The named reference
Remuzat2015was invoked but never defined (see the help page). - ^ Cite error: The named reference
EC2014was invoked but never defined (see the help page). - ^ Cite error: The named reference
WHOHAI2011was invoked but never defined (see the help page). - ^ Cite error: The named reference
Rida2017was invoked but never defined (see the help page). - ^ Bangalee, Varsha; Suleman, Fatima (28 September 2018). "A Comparative Study on Medicine Pricing in Brazil, Russia, India, China and South Africa (BRICS)". Global Journal of Health Science. 10 (10): 152. doi:10.5539/gjhs.v10n10p152.
- ^ Cite error: The named reference
Holtorf2019was invoked but never defined (see the help page). - ^ "Use of External Reference Pricing for Medicines". www.haiweb.org. Health Action International. 2014. Retrieved 28 November 2019.
- ^ Saeed, Amna; Li, Zongjie; Kabba, John Alimamy; Yang, Caijun; Fang, Yu (2019). "External Reference Pricing and Medicines". Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Academic Press. ISBN 978-0-12-812736-0.